Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
10/09/26	HK$0.1470	-4.55%	360,000
09/09/26	HK$0.1540	0.00%	0
08/09/26	HK$0.1540	0.00%	0
07/09/26	HK$0.1540	-1.28%	200,000
04/09/26	HK$0.1560	+7.59%	320,000

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 12:08:43 10/09/2026 +04			5-day change	1st Jan Change
0.1470 ^HKD	-4.55%		+1.38%	+12.21%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	118M 15M 12.9M 12.17M 11.09M 20.72M 1.43B 20.91M 145M 55.78M 727M 56.32M 55.09M 2.31B	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	62.25M 7.94M 6.83M 6.44M 5.87M 10.97M 759M 11.07M 76.72M 29.53M 385M 29.81M 29.16M 1.22B	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	26.97%	Yield 2025	2.31%	Yield 2026	1.91%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
21/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/08/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 day	-4.55%
1 week	+1.38%
Current month	+0.68%
1 month	+15.75%
3 months	-2.00%
6 months	+13.08%
Current year	+12.21%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation : Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Price Extremes

Managers and Directors : Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

1 week	0.14	0.16
1 month	0.13	0.16
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Ka Man Lee SEC	Corporate Secretary	52	24/09/2019

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	01/03/2018
Yin Shun Miu BRD	Director/Board Member	59	18/09/2017
Man Wai Chiu BRD	Director/Board Member	57	18/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	-4.55%	+1.38%	+28.95%	+104.17%	15.71M
HENRY SCHEIN, INC.	-0.35%	-3.45%	+30.14%	+18.10%	9.8B
SHIP HEALTHCARE HOLDINGS, INC.	+0.21%	+0.51%	+5.20%	+0.42%	1.41B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	-1.61%	-4.45%	-	-	1.29B
AS ONE CORPORATION	+1.27%	-1.06%	-4.53%	-14.45%	1.13B
COWEALTH MEDICAL CHINA CO.,LTD.	-3.22%	+5.90%	+93.12%	+56.23%	792M
GKHT MEDICAL TECHNOLOGY CO., LTD.	-1.83%	-2.62%	-23.50%	-54.59%	607M
EXCELSIOR MEDICAL CO., LTD.	+2.54%	+2.25%	-14.15%	-9.41%	424M
NIPPON CARE SUPPLY CO., LTD.	+2.64%	-0.47%	+99.35%	+149.71%	421M
WIN-PARTNERS CO., LTD.	0.00%	-0.24%	-6.51%	+14.05%	224M
Average	-0.49%	-0.83%	+23.12%	+29.36%	1.61B
Weighted average by Cap.	-0.33%	-2.30%	+26.44%	+15.99%

	2025	2026
Net sales	94.45M 12.05M 10.36M 9.77M 8.9M 16.64M 1.15B 16.8M 116M 44.8M 584M 45.23M 44.24M 1.86B	101M 12.84M 11.05M 10.42M 9.49M 17.75M 1.23B 17.91M 124M 47.77M 623M 48.23M 47.18M 1.98B
Net income	9.46M 1.21M 1.04M 979K 892K 1.67M 115M 1.68M 11.66M 4.49M 58.51M 4.53M 4.43M 186M	8.41M 1.07M 923K 871K 793K 1.48M 103M 1.5M 10.37M 3.99M 52.03M 4.03M 3.94M 165M
Net Debt	-62.36M -7.95M -6.84M -6.45M -5.88M -10.99M -760M -11.09M -76.86M -29.58M -386M -29.87M -29.21M -1.23B	-55.35M -7.06M -6.07M -5.73M -5.22M -9.75M -675M -9.84M -68.22M -26.25M -342M -26.51M -25.93M -1.09B